142 related articles for article (PubMed ID: 4146043)
1. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
Nurowska K; Welbel L
Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
[No Abstract] [Full Text] [Related]
2. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
Hollister LE
Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
[No Abstract] [Full Text] [Related]
3. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
[No Abstract] [Full Text] [Related]
4. [Prolonged action neuroleptics (review of the foreign literature)].
Obukhov GA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with Imagotan].
Iscar G
Arch Neurobiol (Madr); 1972; 35(4):367-74. PubMed ID: 4404658
[No Abstract] [Full Text] [Related]
6. Simplified symptom registration in psychiatric trials: a statistical approach.
Hansen V; Hagen AS; Lehmann EH; Astrup C
Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
[No Abstract] [Full Text] [Related]
7. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
Nakra BR; Wickramasinghe NA
Pharmatherapeutica; 1980; 2(5):337-40. PubMed ID: 6107933
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of trifluperidol in chronic schizaphrenia.
Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4917285
[No Abstract] [Full Text] [Related]
9. Piperacetazine study in state hospital patients.
del Portillo L
J Med Assoc Ga; 1974 Dec; 63(12):465-7. PubMed ID: 4154960
[No Abstract] [Full Text] [Related]
10. Three cases of schizophrenia showing improvement after switching to blonanserin.
Kurotaki N; Nobata H; Nonaka S; Nishihara K; Ozawa H
Psychiatry Clin Neurosci; 2011 Jun; 65(4):396-7. PubMed ID: 21682816
[No Abstract] [Full Text] [Related]
11. The position of blonanserin as a treatment for schizophrenia.
Kishi T; Matsuda Y; Iwata N
Asia Pac Psychiatry; 2014 Dec; 6(4):462. PubMed ID: 25425069
[No Abstract] [Full Text] [Related]
12. Evaluation of trifluperidol in chronic schizophrenia.
Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4916807
[No Abstract] [Full Text] [Related]
13. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Martin IC
Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
[TBL] [Abstract][Full Text] [Related]
14. Risperidone for chronic schizophrenia.
Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
[No Abstract] [Full Text] [Related]
15. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
16. Schizophrenia drug gets negative results for negative symptoms.
Kingwell K
Nat Rev Drug Discov; 2014 Apr; 13(4):244-5. PubMed ID: 24687052
[No Abstract] [Full Text] [Related]
17. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
18. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
[No Abstract] [Full Text] [Related]
19. The interaction between neuroleptic treatment and sociotherapeutic approach in chronic schizophrenics. Investigations with haloperidol, penfluridol and pimozide.
Baro F; Dom R
Acta Psychiatr Belg; 1976; 76(5):735-58. PubMed ID: 1030923
[TBL] [Abstract][Full Text] [Related]
20. A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
Astrup C; Grimgård A; Hebnes K; Kruse-Jensen A; Lid M
Acta Psychiatr Scand; 1974; 50(5):481-91. PubMed ID: 4156624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
